Morgan Stanley Maintains Overweight on Compass Pathways, Raises Price Target to $18

Benzinga Newsdesk www.benzinga.com Positive 66.6%

Neg 0% Neu 0% Pos 66.6%

Morgan Stanley analyst Judah Frommer maintains Compass Pathways (NASDAQ:CMPS) with a Overweight and raises the price target from $17 to $18.